2013
DOI: 10.1016/s1473-3099(12)70277-3
|View full text |Cite
|
Sign up to set email alerts
|

Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study

Abstract: SummaryBackgroundTuberculosis incidence in the UK has risen in the past decade. Disease control depends on epidemiological data, which can be difficult to obtain. Whole-genome sequencing can detect microevolution within Mycobacterium tuberculosis strains. We aimed to estimate the genetic diversity of related M tuberculosis strains in the UK Midlands and to investigate how this measurement might be used to investigate community outbreaks.MethodsIn a retrospective observational study, we used Illumina technology… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

48
998
7
2

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 817 publications
(1,083 citation statements)
references
References 28 publications
48
998
7
2
Order By: Relevance
“…Thus, we find an average molecular clock rate of 0.2 -0.3 SNPs per genome per year. Interestingly, this compares quite well to rates of mutation acquisition observed previously in Lineage 4, both in vitro (Ford et al, 2011;Ford et al, 2013) and in several independent retrospective outbreak studies (Eldholm et al, 2015;Guerra-Assuncao et al, 2015;Walker et al, 2013). While current models of Mtb during latency assume that there is little or no growth or mutation of the infecting bacteria, a recent in vitro study using a macaque model has provided evidence that Mtb mutates at a fixed rate over time, and that mutation rates are comparable between latent and active disease (Ford et al, 2011).…”
Section: Molecular Clock Ratessupporting
confidence: 87%
“…Thus, we find an average molecular clock rate of 0.2 -0.3 SNPs per genome per year. Interestingly, this compares quite well to rates of mutation acquisition observed previously in Lineage 4, both in vitro (Ford et al, 2011;Ford et al, 2013) and in several independent retrospective outbreak studies (Eldholm et al, 2015;Guerra-Assuncao et al, 2015;Walker et al, 2013). While current models of Mtb during latency assume that there is little or no growth or mutation of the infecting bacteria, a recent in vitro study using a macaque model has provided evidence that Mtb mutates at a fixed rate over time, and that mutation rates are comparable between latent and active disease (Ford et al, 2011).…”
Section: Molecular Clock Ratessupporting
confidence: 87%
“…SNP=single-nucleotide polymorphism. [74][75][76][77][78] Comprehensive analysis of the genome of the pathogen Requires culture (or specimen enrichment); more expensive; might be computationally demanding or complex Identification of transmission chains, mutations conferring resistance, heteroresistance (low resolution), mixed infections, specimen heterogeneity, and intrapatient evolution 82,85,90 ahpC, 93 and 16S rRNA. 94 Highly transmissible MDR outbreak clones with specific combinations of low-cost resistance and compensatory mutations have already emerged in several areas of the world.…”
Section: Clustermentioning
confidence: 99%
“…137,138 As with other typing methods, transmission of M tuberculosis strains is measured by the relatedness of each strain's whole-genome sequencing results. Recent reports have suggested that strains differing by less than 10 single nucleotide variations reflect transmission 46,74,137,139,140 (figure 4). Deciphering tuberculosis transmission dynamics is crucial for the optimisation of local and global control measures and the early detection of MDR and XDR outbreaks.…”
Section: The Lancet Respiratory Medicine Commissionmentioning
confidence: 99%
“…Mycobacterium tuberculosis is characterized by a low mutation rate (about 2 × 10 −10 mutations/bp/generation) (Ford et al., 2011), with an estimated evolutionary rate of 0.4—0.5 single nucleotide polymorphisms (SNPs)/genome/year and a divergence rarely higher than five SNPs in 3 years (Roetzer et al., 2013; Walker et al., 2013). Despite this low mutation rate, the number of drug resistant, especially MDR and XDR TB cases, due to the acquisition of mutations, is progressively increasing worldwide.…”
Section: Mutation Rate and Drug Resistance Acquisitionmentioning
confidence: 99%